RRM2 and cancer: We speculate that the increased risk of some malignant tumors may be associated with the overexpression of Rrm1 and Rrm2, and the main signaling pathways involved may be related to the HIF-1 signaling pathway, p53 signaling pathway, cell cycle, and apoptosis.